2,087 reports of this reaction
2.4% of all AZITHROMYCIN reports
#6 most reported adverse reaction
PNEUMONIA is the #6 most commonly reported adverse reaction for AZITHROMYCIN, manufactured by AiPing Pharmaceutical, Inc.. There are 2,087 FDA adverse event reports linking AZITHROMYCIN to PNEUMONIA. This represents approximately 2.4% of all 88,134 adverse event reports for this drug.
Patients taking AZITHROMYCIN who experience pneumonia should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.
PNEUMONIA is a less commonly reported adverse event for AZITHROMYCIN, but still significant enough to appear in the safety profile.
In addition to pneumonia, the following adverse reactions have been reported for AZITHROMYCIN:
The following drugs have also been linked to pneumonia in FDA adverse event reports:
PNEUMONIA has been reported as an adverse event in 2,087 FDA reports for AZITHROMYCIN. This does not prove causation, but indicates an association observed in post-market surveillance data.
PNEUMONIA accounts for approximately 2.4% of all adverse event reports for AZITHROMYCIN, making it a notable side effect.
If you experience pneumonia while taking AZITHROMYCIN, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.